Aquilo Capital Management, LLC / ARWR
Aquilo Capital Management, LLC’s Arrowhead Pharmaceuticals In Position
Does Aquilo Capital Management, LLC own Arrowhead Pharmaceuticals In (ARWR)? Not currently — the last reported position was 550.1K shares worth $7M in Q1 2025; the fund’s latest 13F (Q3 2025) no longer reports it.
Position Value
$7M
Q1 2025
Shares
550.1K
% of Portfolio
+12.57%
Quarters Held
23
position exited
Position History ARWR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2025 | 550.1K | $7M | +12.57% |
| Q4 2024 | 707.6K | $13M | +20.06% |
| Q3 2024 | 795.8K | $15M | +11.69% |
| Q2 2024 | 908.5K | $24M | +22.76% |
| Q1 2024 | 908.5K | $26M | +19.47% |
| Q4 2023 | 908.5K | $28M | +17.33% |
| Q3 2023 | 908.5K | $24M | +22.12% |
| Q2 2023 | 858.5K | $31M | +16.96% |
| Q1 2023 | 1.02M | $26M | +10.72% |
| Q4 2022 | 1.10M | $45M | +16.81% |
| Q3 2022 | 1.22M | $40M | +14.52% |
| Q2 2022 | 1.20M | $42M | +14.40% |
| Q1 2022 | 1.05M | $48M | +7.08% |
| Q4 2021 | 700.4K | $46M | +5.27% |
| Q3 2021 | 527.9K | $33M | +5.99% |
| Q2 2021 | 432.9K | $36M | +9.32% |
| Q1 2021 | 407.9K | $27M | +4.89% |
| Q4 2020 | 365.9K | $28M | +5.84% |
| Q3 2020 | 523.4K | $23M | +2.39% |
| Q2 2020 | 563.3K | $24M | +4.91% |
| Q1 2020 | 436.5K | $13M | +4.89% |
| Q2 2019 | 557.5K | $15M | +5.13% |
| Q1 2019 | 982.5K | $18M | +7.98% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aquilo Capital Management, LLC’s full portfolio or all institutional holders of ARWR.